An approach that uses the FIB-4 score along with the results of noninvasive tests can identify high-risk patients with nonalcoholic steatohepatitis without requiring liver biopsies, according to research presented at the 2022 International Liver Congress of the European Association for the Study of the Liver. In a companion study, the same researchers showed that the enhanced liver fibrosis test detects advanced fibrosis as accurately in real-world settings as in clinical
OCTOBER 17, 2022